With the high rate of COVID-19 infections worldwide, the emergence of SARS-CoV-2
variants was inevitable. Several mutations have been identified in the SARS-CoV-2 …

We are living through an unprecedented crisis with the rapid spread of the new coronavirus
disease (COVID-19) worldwide within a short time. The timely availability of thousands of …

Severe acute respiratory syndrome‐coronavirus (SARS‐CoV)‐2′ s origin is still
controversial. Genomic analyses show SARS‐CoV‐2 likely to be chimeric, most of its …

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel epidemic
strain of Betacoronavirus that is responsible for the current viral pandemic, coronavirus …

Nanoparticles provide new opportunities in merging therapeutics and new materials, with
current research efforts just beginning to scratch the surface of their diverse benefits and …

Background At the end of December 2019, a novel strain of Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) disease (COVID-19) has been identified in Wuhan …

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
responsible for the disease COVID-19 that has decimated the health and economy of our …

The use of antiviral COVID-19 medications can successfully inhibit SARS-CoV-2 replication
and prevent disease progression to a more severe form. However, the timing of antiviral …

The ongoing COVID-19 pandemic has created a need for coatings that reduce infection from
SARS-CoV-2 via surfaces. Such a coating could be used on common touch surfaces (eg …

Abstract Coronavirus disease 2019 (COVID-19) is caused by a new member of the
Coronaviridae family known as severe acute respiratory syndrome coronavirus 2 (SARS …